Robert Taylor

Summary

Publications

  1. pmc Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature
    Robert Taylor
    NEMA Research Inc, Naples, FL
    J Pain Res 5:77-87. 2012
  2. pmc Designing opioids that deter abuse
    Robert B Raffa
    Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadelphia, PA 19140, USA
    Pain Res Treat 2012:282981. 2012
  3. pmc Prophylaxis of postoperative nausea and vomiting in adolescent patients: a review with emphasis on combination of fixed-dose ondansetron and transdermal scopolamine
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205 2196, USA
    J Drug Deliv 2011:426813. 2011
  4. doi request reprint Transversus abdominis block: clinical uses, side effects, and future perspectives
    Robert Taylor
    NEMA Research, Naples, Florida, USA
    Pain Pract 13:332-44. 2013
  5. doi request reprint Tapentadol extended release for chronic pain patients
    Robert Taylor
    NEMA Research, Inc, Naples, Florida, USA
    Adv Ther 30:14-27. 2013
  6. doi request reprint A randomized, double-blind comparison shows the addition of oxygenated glycerol triesters to topical mentholated cream for the treatment of acute musculoskeletal pain demonstrates incremental benefit over time
    Robert Taylor
    NEMA Research, Naples, FL, USA
    Pain Pract 12:610-9. 2012
  7. ncbi request reprint New health care measures: emphasis on better management of postsurgical pain and postoperative nausea and vomiting
    Joseph V Pergolizzi
    Adjunct Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Associate Professor of Pharmacology, TemplenUniversity School of Medicine, Philadelphia, PA
    Hosp Pract (1995) 42:65-74. 2014
  8. doi request reprint Opioid antagonists for pain
    Robert Taylor
    NEMA Research, Inc, Naples, FL, USA
    Expert Opin Investig Drugs 22:517-25. 2013
  9. doi request reprint An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in the older adult
    Joseph V Pergolizzi
    NEMA Research Inc, Naples, FL, USA
    J Opioid Manag 8:383-93. 2012
  10. doi request reprint Fixed-dose combinations for emerging treatment of pain
    Robert B Raffa
    Temple University School of Pharmacy, Department of Pharmaceutical Sciences, 3307 N Broad Street, PA 19140, USA
    Expert Opin Pharmacother 13:1261-70. 2012

Collaborators

Detail Information

Publications23

  1. pmc Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature
    Robert Taylor
    NEMA Research Inc, Naples, FL
    J Pain Res 5:77-87. 2012
    ..Analysis of the studies revealed that oxycodone CR is reasonably efficacious, safe, and tolerable when used to manage moderate to severe chronic OA pain, with similar side effects to that of other opioids...
  2. pmc Designing opioids that deter abuse
    Robert B Raffa
    Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, Philadelphia, PA 19140, USA
    Pain Res Treat 2012:282981. 2012
    ..Designing and screening for opioids intended to resist or deter abuse is an important step to meet the public health challenge of burgeoning prescription opioid abuse...
  3. pmc Prophylaxis of postoperative nausea and vomiting in adolescent patients: a review with emphasis on combination of fixed-dose ondansetron and transdermal scopolamine
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205 2196, USA
    J Drug Deliv 2011:426813. 2011
    ..We also review the clinical evidence regarding the safety and efficacy of a fixed-dose combination of ondansetron (4 mg, i.v.) and transdermal scopolamine (1.5 mg)...
  4. doi request reprint Transversus abdominis block: clinical uses, side effects, and future perspectives
    Robert Taylor
    NEMA Research, Naples, Florida, USA
    Pain Pract 13:332-44. 2013
    ....
  5. doi request reprint Tapentadol extended release for chronic pain patients
    Robert Taylor
    NEMA Research, Inc, Naples, Florida, USA
    Adv Ther 30:14-27. 2013
    ..A long-term use analgesic with a good benefit/risk ratio is advantageous...
  6. doi request reprint A randomized, double-blind comparison shows the addition of oxygenated glycerol triesters to topical mentholated cream for the treatment of acute musculoskeletal pain demonstrates incremental benefit over time
    Robert Taylor
    NEMA Research, Naples, FL, USA
    Pain Pract 12:610-9. 2012
    ..Topical analgesics are important products in the armamentarium for pain relief...
  7. ncbi request reprint New health care measures: emphasis on better management of postsurgical pain and postoperative nausea and vomiting
    Joseph V Pergolizzi
    Adjunct Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Associate Professor of Pharmacology, TemplenUniversity School of Medicine, Philadelphia, PA
    Hosp Pract (1995) 42:65-74. 2014
    ..The aim of this review is to raise practitioner awareness of these new quality metrics and provide an overview of the current tools and methods used to improve postoperative pain control and PONV. ..
  8. doi request reprint Opioid antagonists for pain
    Robert Taylor
    NEMA Research, Inc, Naples, FL, USA
    Expert Opin Investig Drugs 22:517-25. 2013
    ..Paradoxically, opioid antagonists have been reported to produce analgesia or enhance analgesia of opioid agonists. The authors review the current state of the clinical use of opioid antagonists as analgesics...
  9. doi request reprint An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in the older adult
    Joseph V Pergolizzi
    NEMA Research Inc, Naples, FL, USA
    J Opioid Manag 8:383-93. 2012
    ..The study of extended-release (ER) oxymorphone in older (≥ 65 years of age) versus younger (18-40 years of age) male and female volunteers was described...
  10. doi request reprint Fixed-dose combinations for emerging treatment of pain
    Robert B Raffa
    Temple University School of Pharmacy, Department of Pharmaceutical Sciences, 3307 N Broad Street, PA 19140, USA
    Expert Opin Pharmacother 13:1261-70. 2012
    ..Better outcomes might be achieved using a combination of analgesics. The ratio of the combinations matters and should therefore be evaluated using rigorous quantitative and well-documented analysis...
  11. doi request reprint Challenges of treating patients with chronic pain with dysphagia (CPD): physician and patient perspectives
    Joseph V Pergolizzi
    Johns Hopkins University School of Medicine, Baltimore, MD, USA, Georgetown University School of Medicine, Washington, DC, USA, and Temple University School of Medicine, Philadelphia, PA, USA
    Curr Med Res Opin 30:191-202. 2014
    ..The objective of this study was to survey physicians and patients in the US to understand their knowledge, attitudes, and clinical management/analgesic usage patterns in the treatment of patients with chronic pain with dysphagia (CPD)...
  12. ncbi request reprint Non-analgesic effects of opioids: factors relevant to opioid abuse and abuse- deterrent formulations
    Joseph V Pergolizzi
    Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA
    Curr Pharm Des 18:6109-15. 2012
    ..Epidemiological studies will have to be conducted to evaluate their effectiveness. Although there are currently more questions than answers, such products are clearly of medical and societal importance...
  13. doi request reprint A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
    Pain Pract 13:239-52. 2013
    ..Its use for antidepressant and anxiolytic actions has been extensively reviewed previously. We here review the evidence for the efficacy of 60 mg once-daily dosing of duloxetine for chronic pain conditions...
  14. doi request reprint Treating acute pain in light of the chronification of pain
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Anesthesiology, Georgetown University School of Medicine, Washington, District of Columbia Department of Pharmacology, School of Medicine, Philadelphia, Pennsylvania
    Pain Manag Nurs 15:380-90. 2014
    ..By interrupting nociceptive input in acute pain conditions, it might be possible to prevent transition to chronic pain syndromes. ..
  15. doi request reprint Extended-release formulations of tramadol in the treatment of chronic pain
    Joseph V Pergolizzi
    Johns Hopkins University School of Medicine, Department of Medicine, Baltimore, MD, USA
    Expert Opin Pharmacother 12:1757-68. 2011
    ....
  16. doi request reprint Continuous multimechanistic postoperative analgesia: a rationale for transitioning from intravenous acetaminophen and opioids to oral formulations
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Pain Pract 12:159-73. 2012
    ..For postsurgical analgesia with any acetaminophen product, patient education is necessary to be sure that the patient does not concurrently take any over-the-counter products containing acetaminophen and accidentally exceed dose limits...
  17. doi request reprint Sequestered naltrexone in sustained release morphine or oxycodone - a way to inhibit illicit use?
    Robert B Raffa
    Temple University School of Pharmacy, Department of Pharmaceutical Sciences, Philadelphia, PA, USA
    Expert Opin Drug Saf 13:181-90. 2014
    ..Many abusers tamper with formulations in an effort to convert the active ingredient into a form suitable for alternative and more abuse-desirable routes of administration, such as snorting, inhaling or injecting...
  18. doi request reprint Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA
    J Clin Anesth 24:334-45. 2012
    ..59, 95% CI, 0.48-0.73, P < 0.001), postoperative vomiting (RR=0.68, 95% CI, 0.61-0.76, P < 0.001), and PONV (RR 0.73, 95% CI, 0.60-0.88, P = 001) in the first 24 hours after the start of anesthesia...
  19. doi request reprint Dynamic risk factors in the misuse of opioid analgesics
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Psychosom Res 72:443-51. 2012
    ..Identify the risk factors for prescription opioid misuse among patients taking prescription opioids to deal with chronic pain...
  20. pmc Perspectives on the role of fospropofol in the monitored anesthesia care setting
    Joseph V Pergolizzi
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205 2196, USA
    Anesthesiol Res Pract 2011:458920. 2011
    ..Fospropofol is a promising new sedation agent that appears to be well suited for MAC sedation, but further studies are needed to better understand its PK/PD properties as well its appropriate clinical role in outpatient procedures...
  21. pmc Pain Management in the Elderly: An FDA Safe Use Initiative Expert Panel's View on Preventable Harm Associated with NSAID Therapy
    Robert Taylor
    NEMA Research Inc, 840 111th Avenue North Suite no 9, Naples, FL 34108, USA
    Curr Gerontol Geriatr Res 2012:196159. 2012
    ..The panel suggested one focus could be the use of NSAIDs for pain management in the elderly...